FULGENT GENETICS, INC. Payments To Acquire Equity Securities Fv Ni
FULGENT GENETICS, INC. (FLGT) reported Payments To Acquire Equity Securities Fv Ni of $15.00 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquitySecuritiesFvNi · last filed 2023-11-03
- FULGENT GENETICS, INC. payments to acquire equity securities fv ni for the quarter ending 2022-09-30 was $0.00.
- FULGENT GENETICS, INC. payments to acquire equity securities fv ni for the quarter ending 2022-06-30 was $0.00.
- FULGENT GENETICS, INC. payments to acquire equity securities fv ni for the quarter ending 2022-03-31 was $15.00M.
| Period end | Payments To Acquire Equity Securities Fv Ni 3 month | Payments To Acquire Equity Securities Fv Ni 6 month | Payments To Acquire Equity Securities Fv Ni 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $15.00M 10-Q · filed 2023-11-03 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $15.00M 10-Q · filed 2023-08-04 | |
| 2022-03-31 | $15.00M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |